{{NoteTA
|1=zh-cn:人流;zh-hk:墮胎;
}}
{{Infobox Birth control
|name = 复合口服避孕药(COCP)
|image = Pilule contraceptive.jpg
|width =
|caption =
|bc_type = [[激素|激素]]
|rate_type = 失效
|perfect_failure% = 0.3<ref name="Trussell 2011">{{cite book|last=Trussell|first=James|year=2011|chapter=Contraceptive efficacy |editor1-last=Hatcher|editor1-first=Robert A.|editor2-last=Trussell |editor2-first=James|editor3-last=Nelson|editor3-first=Anita L.|editor4-last=Cates|editor4-first=Willard Jr.|editor5-last= Kowal|editor5-first=Deborah|editor6-last=Policar|editor6-first=Michael S. (eds.)|title=Contraceptive technology|edition=20th revised|location=New York|publisher=Ardent Media|isbn=978-1-59708-004-0|issn = 0091-9721|oclc=781956734|pages=779–863}} Table 26–1 = <span class="plainlinks">[http://www.contraceptivetechnology.org/wp-content/uploads/2013/09/CTFailureTable.pdf Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States.] {{Wayback|url=http://www.contraceptivetechnology.org/wp-content/uploads/2013/09/CTFailureTable.pdf |date=20131112130150 }}</span></ref>
|typical_failure% = 9<ref name="Trussell 2011"/>
|duration_effect = 1–4日<!-- depending where in pack/cycle, EC required after 1–4 days missed -->
|reversibility = 是
|user_reminders = 每天同一时间服用
|clinic_interval = 6个月
|STD_protection_YesNo = 否
|periods = 可能减少疼痛<!--Regulates, and often lighter and less painful-->
|benefits = 减少死亡风险<ref name="Hannaford 2010">{{cite journal|last1=Hannaford|first1=Philip C.|last2=Iversen|first2=Lisa|last3=Macfarlane|first3=Tatiana V.|last4=Elliot|first4=Alison|last5=Angus|first5=Valerie|last6=Lee|first6=Amanda J.|date=March 11, 2010|title=Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study|journal=BMJ|volume=340|page=c927|doi=10.1136/bmj.c927|pmc=2837145|pmid=20223876}}</ref>，减少各种癌症死亡概率<ref name="Hannaford 2010"/>。减少[[卵巢癌|卵巢癌]]和[[子宫内膜癌|子宫内膜癌]]风险。可治疗[[粉刺|粉刺]]、[[多囊卵巢綜合症|多囊卵巢綜合症]]、 [[经前焦虑症|经前焦虑症]]、 [[子宮內膜異位症|子宮內膜異位症]]
|weight_gain_loss = 否
|risks = [[不育|不育]]、某些癌症<ref name="IARC2007">{{Cite journal|publisher=[[International_Agency_for_Research_on_Cancer|International Agency for Research on Cancer]]|work=IARC Monographs on the Evaluation of Carcinogenic Risks to Humans|volume=91|year=2007|title=Combined Estrogen-Progestogen Contraceptives|format=PDF|url=http://monographs.iarc.fr/ENG/Monographs/vol91/mono91-6.pdf|author1=IARC working group|journal=|access-date=2014-04-21|archive-date=2016-08-03|archive-url=https://web.archive.org/web/20160803085912/http://monographs.iarc.fr/ENG/Monographs/vol91/mono91-6.pdf|dead-url=no}}</ref><ref name="oxford 1996a"/>，[[DVT|DVT]]，[[中風|中風]]<ref name="KemmerenEtAl2002">{{cite journal|doi=10.1161/01.STR.0000015345.61324.3F |title=Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study: Oral Contraceptives and the Risk of Ischemic Stroke |url=https://archive.org/details/sim_stroke_2002-05_33_5/page/1202 |year=2002 |last1=Kemmeren |first1=J. M. |journal=Stroke |volume=33 |issue=5 |pages=1202–8 |pmid=11988591 |last2=Tanis |first2=BC |last3=Van Den Bosch |first3=MA |last4=Bollen |first4=EL |last5=Helmerhorst |first5=FM |last6=Van Der Graaf |first6=Y |last7=Rosendaal |first7=FR |last8=Algra |first8=A}}</ref>， [[心血管疾病|心血管疾病]]<ref name="BaillargeonMcClishEssahNestler2004">{{cite journal |doi=10.1210/jc.2004-1958 |title=Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis |year=2005 |last1=Baillargeon |first1=J.-P. |journal=Journal of Clinical Endocrinology & Metabolism |volume=90 |issue=7 |pages=3863–70 |pmid=15814774}}</ref>
|medical_notes = 与抗生素[[利福平|利福平]]<ref>{{Cite web |url=http://www.plannedparenthood.org/health-topics/birth-control/birth-control-pill-4228.htm |title=Planned Parenthood - Birth Control Pills |access-date=2014-04-21 |archive-date=2011-08-05 |archive-url=https://web.archive.org/web/20110805151417/http://www.plannedparenthood.org/health-topics/birth-control/birth-control-pill-4228.htm |dead-url=no }}</ref>，金丝桃和一些抗癫痫药相抵触, 也有呕吐和腹泻。有偏头痛历史者应小心。
|date_first_use = 1960年：{{USA}}
}}{{Redirect2|短效避孕药|紧急避孕药或长效避孕药|避孕药}}{{medical}}

'''复合口服避孕药'''，也叫'''复方口服避孕药'''，是目前最常见的[[避孕药|避孕药]]。它是一种通过服用复合[[雌激素|雌激素]]和[[孕激素|孕激素]]来控制生育的方法。如[[女性|女性]]正确地根据药物说明，每日规律服用这种药，可达到[[避孕|避孕]]的效果。在1960年，[[美国|美国]]第一次批准使用避孕药，使之成为非常普及的[[生育控制|生育控制]]方法。目前（2015年）世界上约有8.8%的已婚或同居育龄妇女（15-49岁）采用各类[[避孕药|避孕药]]避孕<ref name="UN2015">{{cite book|author=UN,  Department of Economic and Social Affairs, Population Division|year=2015|title=Trends in Contraceptive Use Worldwide 2015|location=New York|publisher=United Nations|isbn=978-92-1-151546-6|url=https://www.un.org/en/development/desa/population/publications/pdf/family/trendsContraceptiveUse2015Report.pdf|format=PDF|first=|pages=51|access-date=2019-07-23|archive-date=2020-02-14|archive-url=https://web.archive.org/web/20200214012553/https://www.un.org/en/development/desa/population/publications/pdf/family/trendsContraceptiveUse2015Report.pdf|dead-url=no}}</ref>。它的使用受到不同的国家<ref name="UN2015" />、年龄<ref>{{Cite web|title=行政院性別平等會-性別統計資料庫|url=https://www.gender.ey.gov.tw/gecdb/Stat_Statistics_DetailData.aspx?sn=EncPAucRcZsm6MLYqe2Jkw==|accessdate=2019-07-23|work=www.gender.ey.gov.tw|archive-date=2020-08-09|archive-url=https://web.archive.org/web/20200809144924/https://www.gender.ey.gov.tw/gecdb/Stat_Statistics_DetailData.aspx?sn=EncPAucRcZsm6MLYqe2Jkw%3D%3D|dead-url=no}}</ref>、教育、收入和结婚状态等<ref name="US contraception use">{{cite journal |author=Mosher WD, Martinez GM, Chandra A, Abma JC, Willson SJ |year=2004 |title=Use of contraception and use of family planning services in the United States: 1982–2002 |journal=Adv Data |issue=350 |pages=1–36 |pmid=15633582 |url=http://www.cdc.gov/nchs/data/ad/ad350.pdf |format=PDF |access-date=2010-03-12 |archive-date=2021-01-26 |archive-url=https://web.archive.org/web/20210126153736/https://www.cdc.gov/nchs/data/ad/ad350.pdf |dead-url=no }}</ref>因素的影响。大约960万（15.6%育龄）美国妇女使用口服避孕药（2014年）<ref>{{Cite web|title=Contraceptive Use in the United States|url=https://www.guttmacher.org/fact-sheet/contraceptive-use-united-states|accessdate=2019-07-23|author=|date=2018-07|format=|work=Guttmacher Institute|publisher=|language=en|archive-date=2016-12-11|archive-url=https://web.archive.org/web/20161211050342/https://www.guttmacher.org/fact-sheet/contraceptive-use-united-states|dead-url=no}}</ref>，四分之一16-49岁的英国妇女服用避孕药（2005年）<!--
  --><ref name="taylor">{{cite book|author=Taylor, Tamara; Keyse, Laura; Bryant, Aimee|year=2006|title=Contraception and Sexual Health, 2005/06|location=London|publisher=Office for National Statistics|isbn=1-85774-638-4|url=http://www.statistics.gov.uk/downloads/theme_health/contraception2005-06.pdf|format=PDF|archiveurl=http://webarchive.nationalarchives.gov.uk/20070109053900/http://www.statistics.gov.uk/downloads/theme_health/contraception2005-06.pdf|archivedate=2007-01-09}} 16–49英国女性: 24% (17% 使用复合避孕药, 5% 使用仅孕激素避孕药, 2% 避孕药类型未知) </ref>，在日本（1950-2014年数据）只有3%的妇女使用避孕药<!--
  最近研究显示 3% 日本女性使用口服避孕药. --><ref name="Yoshida 2016">{{cite journal | vauthors = Yoshida H, Sakamoto H, Leslie A, Takahashi O, Tsuboi S, Kitamura K | title = Contraception in Japan: Current trends | journal = Contraception | volume = 93 | issue = 6 | pages = 475–7 | date = June 2016 | pmid = 26872717 | doi = 10.1016/j.contraception.2016.02.006 }}</ref>。

对避孕药副作用的争议一直不断。经过数十年的研究，医学界已经基本确认复合口服避孕药不会造成癌症以及肥胖，并且普遍认为，相对意外怀孕造成的危害，服用避孕药对妇女健康利远大于弊。因为无论对于第一年新使用者还是有经验的完美使用者，避孕药都是目前失败率最低的避孕手段。<ref name=humreprod>{{cite journal |author=Gupta S |title=Weight gain on the combined pill—is it real? |journal=Hum Reprod Update |volume=6 |issue=5 |pages=427–31 |year=2000 |pmid=11045873 | doi = 10.1093/humupd/6.5.427}}</ref><ref name="oxford 1996a">{{cite journal |author=Collaborative Group on Hormonal Factors in Breast Cancer |year=1996 |title=Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies |journal=[[The_Lancet|Lancet]] |volume=347 |issue=9017 |pages=1713–27 |pmid=8656904 |doi=10.1016/S0140-6736(96)90806-5}}</ref>

注：本条目中单指'''避孕药'''(The Pill)时意为'''复合避孕药'''(COCP)和[[单一激素避孕药|单一激素避孕药]](POP)的统称，因为一些研究将两种短效口服避孕药一起统计，而两种药的全部统计结果基本适用于复合避孕药。因为复合避孕药效果好，而目前单一激素避孕药对乳腺癌的影响仍然不确定而且服用时间限制严格，因此一直以来普遍使用的'''短效口服避孕药'''基本都是复合避孕药。<ref name=iarc72>{{cite book |author=IARC Working Group on the Evaluation of Carcinogenic Risks to Humans |title=Hormonal contraception and post-menopausal hormonal therapy; IARC monographs on the evaluation of carcinogenic risks to humans, Volume 72 |year=1999 |publisher=IARC Press |location=Lyon |isbn=92-832-1272-X |pages=339–397 |chapter=Hormonal contraceptives, progestogens only |chapterurl=http://www.inchem.org/documents/iarc/vol72/vol72-2.html |access-date=2010-03-15 |archive-date=2006-09-28 |archive-url=https://web.archive.org/web/20060928033515/http://www.inchem.org/documents/iarc/vol72/vol72-2.html |dead-url=no }}</ref>

==历史==
===孕激素的排卵抑制效果===
1930年代时，Andriy Stynhach已经提纯了[[类固醇|类固醇]][[激素|激素]]，例如[[雄激素|雄激素]]、[[雌激素|雌激素]]和[[孕激素|孕激素]]，并且发现高剂量的类固醇激素可以抑制[[排卵|排卵]]<!--
 --><ref name="goldzieher 1974">{{cite journal |author=Goldzieher JW, Rudel HW |year=1974 |title=How the oral contraceptives came to be developed |journal=[[Journal_of_the_American_Medical_Association|JAMA]] |volume=230 |issue=3 |pages=421–5 |pmid=4606623 |doi=10.1001/jama.230.3.421}}</ref><!--
 --><ref name="goldzieher 1982">{{cite journal |author=Goldzieher JW |year=1982 |title=Estrogens in oral contraceptives: historical perspective |journal=Johns Hopkins Med J |volume=150 |issue=5 |pages=165–9 |pmid=7043034}}</ref><!--
 --><ref name="perone 1974">{{cite journal |author=Perone N |year=1993 |title=The history of steroidal contraceptive development: the progestins |url=https://archive.org/details/sim_perspectives-in-biology-and-medicine_spring-1993_36_3/page/347 |journal=Perspect Biol Med |volume=36 |issue=3 |pages=347–62 |pmid=8506121}}</ref><!--
 --><ref name="goldzieher 1993">{{cite journal |author=Goldzieher JW |year= 1993 |title=The history of steroidal contraceptive development: the estrogens |url=https://archive.org/details/sim_perspectives-in-biology-and-medicine_spring-1993_36_3/page/363 |journal=Perspect Biol Med |volume=36 |issue=3 |pages=363–8 |pmid=8506122}}</ref>，Makepease 等人1937年的研究表明给动物注射[[孕酮|孕酮]]能抑制排卵。<ref name="pmid14232795">{{cite journal | vauthors = Pincus G, Bialy G | title = Drugs Used in Control of Reproduction | journal = Adv Pharmacol | volume = 3 | issue = | pages = 285–313 | date = 1964 | pmid = 14232795 | doi = 10.1016/S1054-3589(08)61115-1 | url = | quote = The original observation of Makepeace et al. (1937) that progesterone inhibited ovulation in the rabbit was substantiated by Pincus and Chang (1953). In women, 300 mg of progesterone per day taken orally resulted in ovulation inhibition in 80% of cases (Pincus, 1956). The high dosage and frequent incidence of breakthrough bleeding limited the practical application of the method. Subsequently, the utilization of potent 19-norsteroids, which could be given orally, opened the field to practical oral contraception.}}</ref>但是从动物体内提炼激素的成本极高。<!--
 --><ref name="maisel">{{cite book |author=Maisel, Albert Q. |year=1965 |title=The Hormone Quest |url=https://archive.org/details/hormonequest00mais |location=New York |publisher=Random House}}</ref>

1939年美國[[宾夕法尼亚州立大学|宾夕法尼亚州立大学]]的[[有机化学|有机化学]][[教授|教授]][[罗素·厄尔·马克|罗素·厄尔·马克]]，发明了用[[植物|植物]]类固醇{{tsl|en|sapogenin||皂苷配基}}合成[[孕酮|孕酮]]的方法。<ref name="asbell">{{cite book |author=Asbell, Bernard |year=1995 |title=The Pill: A Biography of the Drug That Changed the World |url=https://archive.org/details/pillthe00bern |location=New York |publisher=Random House |isbn=0-679-43555-7}}</ref>一开始使用的是取自[[墨西哥菝葜|墨西哥菝葜]]的菝葜皂苷元，成本仍然比较昂贵。经过3年的植物学研究，在墨西哥[[奧里薩巴|奧里薩巴]]附近的雨林中发现几种不可食用的墨西哥薯蓣（''{{tsl|en|Dioscorea mexicana||Dioscorea mexicana}}'' 和''{{tsl|en|Dioscorea composita||Dioscorea composita}}''）中提取的[[皂苷|皂苷]] 更好。皂苷可以在实验室中转化为[[薯蓣皂苷配基|薯蓣皂苷配基]]。他随后离开大学，于1944年在[[墨西哥城|墨西哥城]]合伙创办了 {{tsl|en|Syntex||Syntex}}（该公司50年后被[[罗氏|罗氏]]收购<ref>{{Cite news|title=COMPANY NEWS; Roche Set To Acquire Syntex|url=https://www.nytimes.com/1994/05/03/business/company-news-roche-set-to-acquire-syntex.html|newspaper=The New York Times|date=1994-05-03|accessdate=2019-07-23|issn=0362-4331|language=en-US|first=Milt|last=Freudenheim|archive-date=2019-08-15|archive-url=https://web.archive.org/web/20190815030916/https://www.nytimes.com/1994/05/03/business/company-news-roche-set-to-acquire-syntex.html|dead-url=no}}</ref>）。Syntex打破了欧洲制药公司对类固醇激素的垄断，使[[孕酮|孕酮]]价格在8年内降到了原来的1/200。
<!--
 --><ref name="Speroff 20052"/><!--
 --><ref name="maisel"/><!--
 --><ref name="asbell">{{cite book|last =Asbell|first=Bernard| name-list-format = vanc |year=1995|title=The Pill: A Biography of the Drug That Changed the World|url =https://archive.org/details/pillthe00bern|location=New York|publisher=Random House|isbn=978-0-679-43555-6}}</ref><!--
 --><ref name="lehmann">{{cite journal | vauthors = Lehmann PA, Bolivar A, Quintero R | title = Russell E. Marker. Pioneer of the Mexican steroid industry | url = https://archive.org/details/sim_journal-of-chemical-education_1973-03_50_3/page/195 | journal = Journal of Chemical Education | volume = 50 | issue = 3 | pages = 195–9 | date = March 1973 | pmid = 4569922 | doi = 10.1021/ed050p195 | bibcode = 1973JChEd..50..195L }}</ref><!--
 --><ref name="vaughan">{{cite book|last=Vaughan|first=Paul | name-list-format = vanc |year=1970|title=The Pill on Trial|url=https://archive.org/details/pillontrial0000unse|location=New York|publisher=Coward-McCann|oclc=97780}}</ref><!--
 --><ref name="tone">{{cite book|last=Tone|first=Andrea| name-list-format = vanc |year= 2001|title=Devices & Desires: A History of Contraceptives in America|url=https://archive.org/details/devicesdesireshi00tone|location = New York|publisher=Hill and Wang|isbn=978-0-8090-3817-6}}</ref><!--
 --><ref name="reed">{{cite book|last=Reed|first=James| name-list-format = vanc |year=1978|title=From Private Vice to Public Virtue: The Birth Control Movement and American Society Since 1830|url=https://archive.org/details/fromprivatevicet0000reed|location=New York|publisher=Basic Books|isbn=978-0-465-02582-4}}</ref><!--
 --><ref name="mclaughlin">{{cite book|last=McLaughlin|first=Loretta| name-list-format = vanc |year=1982|title=The Pill, John Rock, and the Church: The Biography of a Revolution|url=https://archive.org/details/pilljohnrock00mcla|location=Boston|publisher=Little, Brown|isbn=978-0-316-56095-5}}</ref><!--
 --><ref name="marks">{{cite book|last=Marks|first=Lara| name-list-format = vanc |year=2001|title=Sexual Chemistry: A History of the Contraceptive Pill|url=https://archive.org/details/sexualchemistryh00mark|location=New Haven|publisher=Yale University Press|isbn=978-0-300-08943-1}}</ref><!--
 --><ref name="watkins">{{cite book|last=Watkins|first=Elizabeth Siegel| name-list-format = vanc |year=1998|title=On the Pill: A Social History of Oral Contraceptives, 1950–1970|url=https://archive.org/details/onpillsocialhist0000watk|location=Baltimore|publisher = Johns Hopkins University Press|isbn=978-0-8018-5876-5}}</ref><!--
 --><ref name="djerassi">{{cite book|last=Djerassi|first=Carl| name-list-format = vanc |year=2001|title=This Man's Pill: Reflections on the 50th Birthday of the Pill|url=https://archive.org/details/thismanspillrefl0000djer|location=Oxford|publisher=Oxford University Press|pages=[https://archive.org/details/thismanspillrefl0000djer/page/11 11]–62|isbn=978-0-19-850872-4}}</ref><!--
 --><ref name="applezweig">{{cite book|last=Applezweig|first=Norman| name-list-format = vanc |year=1962|title=Steroid Drugs|url=https://archive.org/details/steroiddrugs00norm|location=New York|publisher=Blakiston Division, McGraw-Hill |pages=vii–xi, 9–83|oclc=14615096}}</ref><!--
 --><ref name="gereffi">{{cite book|last=Gereffi|first=Gary| name-list-format = vanc |year=1983|title=The Pharmaceutical Industry and Dependency in the Third World|url=https://archive.org/details/pharmaceuticalin0000gere|location=Princeton|publisher=Princeton University Press|pages=[https://archive.org/details/pharmaceuticalin0000gere/page/53 53]–163|isbn=978-0-691-09401-4}}</ref>

1951年，{{tsl|en|Worcester Foundation for Experimental Biology|伍司特实验生物学基金会}}的生殖[[生理学|生理学家]][[格雷戈里·平卡斯|格雷戈里·平卡斯]]和[[張明覺|張明覺]]在兔子身上重复并扩展了Makepeace ''et al.'' 的实验，并于1953年发表，显示了孕酮可以抑制排卵。<ref name="pmid14232795" /><ref name="chang" /> 
通过[[美国计划生育联合会|美国计划生育联合会]]（PPFA）的创始人[[山額夫人|山額夫人]]，避孕运动支持者、[[女性參政權|妇女政权论者]]和[[博愛精神|慈善家]]{{tsl|en|Katharine Dexter McCormick||Katharine Dexter McCormick}}了解到了平卡斯的避孕研究，以及PPFA对该研究兴趣不大而资助微薄的状况。她给予50倍于PPFA的资助来扩大和加速该研究。<!--
 --><ref name="reed"/><!--
 --><ref name="fields">{{cite book|last=Fields|first=Armond| name-list-format = vanc |year=2003|title=Katharine Dexter McCormick: Pioneer for Women's Rights|location=Westport, Conn.|publisher=Prager|isbn=978-0-275-98004-7}}</ref>

平卡斯和 McCormick 招募了[[哈佛医学院|哈佛医学院]][[婦產科學|婦產科學]]临床教授、[[布莱根妇女医院|布莱根妇女医院]]的<!--chief of gynecology-->妇产科主任、治疗[[不孕|不孕]]的专家{{tsl|en|John Rock (American scientist)|约翰·洛克}}来领导对人类女性的临床研究。在1952年的一次学术会议中，平卡斯和洛克发现他们在用相似的手段研究相反的问题。洛克曾经在1952年给80个不孕患者给予持续升高剂量的口服雌激素(从5到30mg/天[[己烯雌酚|己烯雌酚]])和孕酮(从50到300mg/天)来诱导为期3个月的不排卵“{{tsl|en|high-dose estrogen/pseudopregnancy|假孕}}”，4个月之后，15%的患者怀孕了。<!--
 --><ref name="reed"/><!--
 --><ref name="mclaughlin"/><!--
 --><ref name="rock 1957b">{{cite journal | vauthors = Rock J, Garcia CR, Pincus G | title = Synthetic progestins in the normal human menstrual cycle | journal = Recent Progress in Hormone Research | volume = 13 | pages = 323–39; discussion 339–46 | year = 1957 | pmid = 13477811 }}</ref>
1953年，根据平卡斯的建议，洛克又在他的27名不孕症患者中诱导了一个为期3个月的假孕期，这次每天口服均为300mg/天，且间断服用，只在[[月经周期|月经周期]]第5-24天连续服用20天，之后停药诱发[[撤退性出血|撤退性出血]]模拟月经来潮。<ref name="pincus 1958b">{{cite journal | vauthors = Pincus G | title = The hormonal control of ovulation and early development | url = https://archive.org/details/sim_postgraduate-medicine_1958-12_24_6/page/654 | journal = Postgraduate Medicine | volume = 24 | issue = 6 | pages = 654–60 | date = December 1958 | pmid = 13614060 | doi = 10.1080/00325481.1958.11692305 }}</ref>这在接下来的四个月内产生了相同的15％怀孕率，且没有先前持续的雌激素和孕酮方案引发的[[闭经|闭经]]。<ref name="pincus 1958b" />但是，20％的女性经历了{{tsl|en|breakthrough bleeding|突破性出血}}（异常阴道出血），在第一个周期，只有85％的女性没有排卵，这表明需要更高和更昂贵的口服黄体酮才能从一开始就持续抑制排卵。<ref name="pincus 1958b" />Ishikawa及其同事发现了类似的结果，300毫克/天口服孕酮只能让“一定比例”的人不排卵。<ref name="Pincus1959">{{cite journal|last1=Pincus|first1=Gregory|title=Progestational Agents and the Control of Fertility|volume=17|year=1959|pages=307–324|issn=0083-6729|doi=10.1016/S0083-6729(08)60274-5|quote=Ishikawa et al. (1957) employing the same regime of progesterone administration also observed suppression of ovulation in a proportion of the cases taken to laparotomy. Although sexual intercourse was practised freely by the subjects of our experiments and those of Ishikawa el al., no pregnancies occurred. Since ovulation presumably took place in a proportion of cycles, the lack of any pregnancies may be due to chance, but Ishikawa et al. (1957) have presented data indicating that in women receiving oral progesterone the cervical mucus becomes impenetrable to sperm.}}</ref>尽管口服孕酮对排卵的抑制作用不完全，但两项研究中假孕的3个月内均没有发生妊娠，尽管这可能仅仅是偶然的原因。<ref name="Pincus1959" /><ref name="pmid5848673">{{cite journal | vauthors = Diczfalusy E | title = Probable mode of action of oral contraceptives | journal = Br Med J | volume = 2 | issue = 5475 | pages = 1394–9 | date = December 1965 | pmid = 5848673 | pmc = 1847181 | doi = 10.1136/bmj.2.5475.1394 | url = | quote = At the Fifth International Conference on Planned Parenthood in Tokyo, Pincus (1955) reported an ovulation inhibition by progesterone or norethynodrel1 taken orally by women. This report indicated the beginning of a new era in the history of contraception. [...] That the cervical mucus might be one of the principal sites of action was suggested by the first studies of Pincus (1956, 1959) and of Ishikawa et al. (1957). These investigators found that no pregnancies occurred in women treated orally with large doses of progesterone, though ovulation was inhibited only in some 70% of the cases studied. [...] The mechanism of protection in this method—and probably in that of Pincus (1956) and of Ishikawa et al. (1957)—must involve an effect on the cervical mucus and/or endometrium and Fallopian tubes.}}</ref> 但是，''Ishikawa et al.'' 报道，服用口服黄体酮的妇女的宫颈粘液变得难以接受精子，这可能是她们没有怀孕的原因。<ref name="Pincus1959" /><ref name="pmid5848673" />

经过上述临床研究，由于需要更高剂量致使成本昂贵、不完全的排卵抑制作用，以及太容易造成突破性出血，用孕酮作口服避孕药的方案被抛弃了<ref name="pmid14232795">{{cite journal | vauthors = Pincus G, Bialy G | title = Drugs Used in Control of Reproduction | journal = Adv Pharmacol | volume = 3 | issue = | pages = 285–313 | date = 1964 | pmid = 14232795 | doi = 10.1016/S1054-3589(08)61115-1 | url = | quote = The original observation of Makepeace et al. (1937) that progesterone inhibited ovulation in the rabbit was substantiated by Pincus and Chang (1953). In women, 300 mg of progesterone per day taken orally resulted in ovulation inhibition in 80% of cases (Pincus, 1956). The high dosage and frequent incidence of breakthrough bleeding limited the practical application of the method. Subsequently, the utilization of potent 19-norsteroids, which could be given orally, opened the field to practical oral contraception.}}</ref><ref name="ArellanoSeipp2017">{{cite book|author1=Annette B. Ramírez de Arellano|author2=Conrad Seipp|title=Colonialism, Catholicism, and Contraception: A History of Birth Control in Puerto Rico|url=https://books.google.com/books?id=0fs4DwAAQBAJ&pg=PT107|date=10 October 2017|publisher=University of North Carolina Press|isbn=978-1-4696-4001-3|pages=107–|quote=[...] Still, neither of the two researchers was completely satisfied with the results. Progesterone tended to cause "premature menses," or breakthrough bleeding, in approximately 20 percent of the cycles, an occurrence that disturbed the patients and worried Rock.17 In addition, Pincus was concerned about the failure to inhibit ovulation in all the cases. Only large doses of orally administered progesterone could insure the suppression of ovulation, and these doses were expensive. The mass use of this regimen as a birth control method was thus seriously imperiled.18 [...]|access-date=2019-07-23|archive-date=2021-06-25|archive-url=https://web.archive.org/web/20210625185119/https://books.google.com/books?id=0fs4DwAAQBAJ&pg=PT107|dead-url=no}}</ref> ，取而代之的是合成的[[黄体制剂|黄体制剂]]<ref name="pmid14232795" /><ref name="ArellanoSeipp2017" />。通过平卡斯与医药企业的良好关系，[[張明覺|張明覺]]与他的合作者得以从数百种化合物中筛查具有孕酮活性的药物。1956年，该系列研究发现，最有效防止动物怀孕的药物是 Syntex 的[[炔诺酮|炔诺酮]]和 G.D. Searle 的[[异炔诺酮|异炔诺酮]]和[[诺乙雄龙|诺乙雄龙]]<!--
 --><ref name="chang">{{cite journal | vauthors = Chang MC | title = Development of the oral contraceptives | journal = American Journal of Obstetrics and Gynecology | volume = 132 | issue = 2 | pages = 217–9 | date = September 1978 | pmid = 356615 | doi = 10.1016/0002-9378(78)90928-6 }}</ref>。 [[炔诺酮|炔诺酮]]（英语：Norethisterone 或 英语：norethindrone）由Syntex的化学家[[卡尔·杰拉西|卡尔·杰拉西]]、{{tsl|en|Luis E. Miramontes||Luis Miramontes}}和{{tsl|en|George Rosenkranz||George Rosenkranz}} 在1951在墨西哥城合成；[[异炔诺酮|异炔诺酮]]（英语：Noretynodrel 或 英语：norethynodrel，炔诺酮的一种同分异构体）由 Searle 的{{tsl|en|Frank B. Colton||Frank B. Colton}}在[[伊利诺伊州|伊利诺伊州]]在1952年合成，[[诺乙雄龙|诺乙雄龙]]（英语：norethandrolone）在1953年合成.<!--
 --><ref name="maisel"/>
1954年12月，洛克对三种人工孕激素的排卵抑制效果开展了首次临床研究，为期三个月，50位不孕患者，每月服药21天（月经周期第5-25天，之后停药出血），每天5–50 mg。5 mg的
炔诺酮或异炔诺酮或任何剂量的诺乙雄龙都能抑制排卵，但是会造成[[突破性出血|突破性出血]]；10 mg或以上的炔诺酮或异炔诺酮则能在不造成突破性出血的情况下抑制排卵，且随后的5个月内有14%的怀孕率。平卡斯和洛克最终选择 Searle 的异炔诺酮作第一次避孕临床实验的候选药物，援引了动物测试中 Syntex 的炔诺酮轻微的[[雄激素|雄激素]]活性。<!--
 --><ref name="garcia">{{cite journal | vauthors = Garcia CR, Pincus G, Rock J | title = Effects of certain 19-nor steroids on the normal human menstrual cycle | journal = Science | volume = 124 | issue = 3227 | pages = 891–3 | date = November 1956 | pmid = 13380401 | doi = 10.1126/science.124.3227.891 | bibcode = 1956Sci...124..891R }}</ref><!--
 --><ref name="rock 1957a">{{cite book|last1=Rock|first1=John|last2=García|first2=Celso-Ramón| name-list-format = vanc |year=1957|chapter=Observed effects of 19-nor steroids on ovulation and menstruation|title=Proceedings of a Symposium on 19-Nor Progestational Steroids|location=Chicago|publisher=Searle Research Laboratories|pages=14–31|oclc=935295}}</ref>

===复合雌激素与孕激素===
随后人们发现炔诺酮和异炔诺酮中都混入了一定水平的中间产物{{tsl|en|mestranol|炔雌醇甲醚}}（英语：mestranol，又称美雌醇）。该物质为一种[[雌激素|雌激素]]。在洛克1954-55年的临床研究中，混入的美雌醇比例为4-7%，如若进一步提纯将美雌醇比例降低到1%则会引发突破性出血。于是美雌醇被作为添加剂有意加入异炔诺酮制剂中，以达到2.2%，这个比例是在1956年的避孕临床研究（见下）中被发现与突破性出血不相关的。异炔诺酮与美雌醇的混合制剂被给予商品名 '''Enovid'''。

<!--
 --><ref name="rock 1957a"/><!--
 --><ref name="pincus 1958a">{{cite journal | vauthors = Pincus G, Rock J, Garcia CR, Ricewray E, Paniagua M, Rodriguez I | title = Fertility control with oral medication | url = https://archive.org/details/sim_american-journal-of-obstetrics-and-gynecology_1958-06_75_6/page/1333 | journal = American Journal of Obstetrics and Gynecology | volume = 75 | issue = 6 | pages = 1333–46 | date = June 1958 | pmid = 13545267 | doi = 10.1016/0002-9378(58)90722-1 }}</ref>

异炔诺酮的首次避孕临床测试于1956在美国的非建制属地[[波多黎各|波多黎各]]开展。<ref name="Segal 2003">{{cite book|last=Segal|first=Sheldon J.| name-list-format = vanc |year=2003|chapter=The Pill and the IUD Modernized Contraception|title=Under the Banyan Tree: A Population Scientist's Odyssey|url=https://archive.org/details/underbanyantreep00sega|location=Oxford |publisher=Oxford University Press|pages=<span class="plainlinks">[https://books.google.com/books?id=1sNWaJ2LQgYC&pg=PA70 70]</span>–<span class="plainlinks">[https://books.google.com/books?id=1sNWaJ2LQgYC&pg=PA78 78]</span>|isbn=978-0-19-515456-6}}</ref><ref name="Garcia 2004">{{cite journal | vauthors = García CR | title = Development of the pill | journal = Annals of the New York Academy of Sciences | volume = 1038 | pages = 223–6 | date = December 2004 | pmid = 15838117 | doi = 10.1196/annals.1315.031 | bibcode = 2004NYASA1038..223G }}</ref><ref name="Strauss 2005">{{cite journal | vauthors = Strauss JF, Mastroianni L | title = In memoriam: Celso-Ramon Garcia, M.D. (1922-2004), reproductive medicine visionary | journal = Journal of Experimental & Clinical Assisted Reproduction | volume = 2 | issue = 1 | pages = 2 | date = January 2005 | pmid = 15673473 | pmc = 548289 | doi = 10.1186/1743-1050-2-2 }}</ref><ref name="junod">{{cite journal | vauthors = Junod SW, Marks L | title = Women's trials: the approval of the first oral contraceptive pill in the United States and Great Britain | journal = Journal of the History of Medicine and Allied Sciences | volume = 57 | issue = 2 | pages = 117–60 | date = April 2002 | pmid = 11995593 | doi = 10.1093/jhmas/57.2.117 | url = http://jhmas.oxfordjournals.org/content/57/2/117.full.pdf | access-date = 2019-07-23 | archive-date = 2012-07-03 | archive-url = https://web.archive.org/web/20120703191844/http://jhmas.oxfordjournals.org/content/57/2/117.full.pdf | dead-url = no }}</ref><ref name="ramirez de arellano">{{cite book|last1=Ramírez de Arellano|first1=Annette B.|last2=Seipp|first2=Conrad| name-list-format = vanc |year=1983|title=Colonialism, Catholicism, and Contraception: A History of Birth Control in Puerto Rico|location=Chapel Hill|publisher=University of North Carolina Press|isbn=978-0-8078-1544-1}}</ref><ref name="rice-wray">{{cite book|last=Rice-Wray|first=Edris| name-list-format = vanc |year=1957|chapter=Field Study with Enovid as a Contraceptive Agent|title=Proceedings of a Symposium on 19-Nor Progestational Steroids|location=Chicago|publisher=Searle Research Laboratorie |pages=78–85|oclc=935295}}</ref><ref name="Marsh 2008">{{cite book|last1=Marsh|first1=Margaret|last2=Ronner|first2=Wanda| name-list-format = vanc |year=2008|title=The Fertility Doctor: John Rock and the Reproductive Revolution|url=https://archive.org/details/fertilitydoctorj0000mars|location=Baltimore|publisher=The Johns Hopkins University Press|pages=[https://archive.org/details/fertilitydoctorj0000mars/page/188 188]–197|isbn=978-0-8018-9001-7}}</ref> 参与实验的志愿者是寻求生育控制的波多黎各女性，她们并未被告知正在参与的是临床试验，也不知道药物的安全性和有效性有待检验，也不知道药物可能有副作用。<!--
 --><ref name="pbs">{{cite web|url= https://www.pbs.org/wgbh/americanexperience/features/pill-puerto-rico-pill-trials/|title= The Puerto Rico Pill Trials|access-date= 2019-01-19|archive-date= 2021-03-03|archive-url= https://web.archive.org/web/20210303062743/https://www.pbs.org/wgbh/americanexperience/features/pill-puerto-rico-pill-trials/|dead-url= no}}</ref> 1956年6月，第二项对 Enovid 和炔诺酮的避孕试验在美国[[洛杉矶|洛杉矶]]开展<!--
 --><ref name="vaughan"/><!--
 --><ref name="tyler">{{cite journal | vauthors = Tyler ET, Olson HJ | title = Fertility promoting and inhibiting effects of new steroid hormonal substances | journal = Journal of the American Medical Association | volume = 169 | issue = 16 | pages = 1843–54 | date = April 1959 | pmid = 13640942 | doi = 10.1001/jama.1959.03000330015003 }}</ref>。 1957年1月23日，Searle 举办了一场研讨会，回顾了1956年对 Enovid 的不孕治疗和避孕研究，并总结到Enovid中的雌激素含量可以降低33%，以降低雌激素引发的胃肠道副作用风险，又不至于太提升突破性出血风险<!--
 --><ref name="winter 1957">{{cite book|last=Winter|first=Irwin C.| name-list-format = vanc |year=1957|chapter=Summary|title=Proceedings of a Symposium on 19-Nor Progestational Steroids |location=Chicago|publisher=Searle Research Laboratories|pages=120–122|oclc=935295}}</ref>。

== 在亚洲国家的误解 ==
复合避孕药在中国大陸、[[日本|日本]]等[[亚洲|亚洲]]国家存在长期的误解和担忧。原因可能因为早期的长效避孕药和紧急避孕药的副作用较大，而很多民众不能区分不同类型的避孕药，1980年代起，中国大陸大规模推广[[宫内节育器|宫内节育器]]，让人们形成了“节育器最有效”的观念；中国大陸和日本为了防止大肆蔓延的[[性病|性病]]而宣传[[避孕套|避孕套]]是最安全的手段，却混淆了防性传播疾病和防止意外怀孕的安全性。<ref>{{cite press release |title=Djerassi on birth control in Japan - abortion 'yes,' pill 'no' |publisher=Stanford University News Service |date=96-14-02 |url=http://www.stanford.edu/dept/news/pr/96/960214japanabort.html |accessdate=2006-08-23 |archive-url=https://web.archive.org/web/20070106173620/http://www.stanford.edu/dept/news/pr/96/960214japanabort.html |archive-date=2007-01-06 |dead-url=yes }}</ref><ref name="cbs"/><ref name="people">{{cite news|author=青木，吴翔|url=http://scitech.people.com.cn/GB/1057/4326411.html|title=避孕药被中国人误解了 不增重还能防癌|publisher=人民网―《生命时报》|date=2006-04-25|pages=24|accessdate=2010-03-12|archive-date=2016-03-04|archive-url=https://web.archive.org/web/20160304085557/http://scitech.people.com.cn/GB/1057/4326411.html|dead-url=no}}</ref>

日本医学学会曾因为担心避孕药的长期作用和不能防止性病的原因阻止口服避孕药被批准长达将近40年之久。1999年才正式批准，并且要求服用者每2个月接受一次妇科盆腔和性病检查。相对地，在美国和欧洲国家只需要每1-2年做一次常规检查。到2004年止，日本80%的避孕方法为避孕套，或许这是日本[[艾滋病|艾滋病]]比例如此之低的原因，因為避孕藥是完全無法預防或防止任何性傳染疾病的傳播。<ref name="cbs"/>

==使用和包装==
[[Image:pillpacketopen.jpg|frame]]
复合避孕药应该在每天同一时间服用。如果忘记服用一粒并超过12小时，避孕效果会降低。<!--
 --><ref name="mercilon spc">{{cite web |author=[[Organon_International|Organon]] |title=Mercilon SPC (Summary of Product Characteristics |url=http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=5384 |accessdate=2007-04-07 |date=November 2001 |archive-url=https://web.archive.org/web/20070928060153/http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=5384 |archive-date=2007-09-28 |dead-url=yes }}</ref> 多数牌子的避孕药都是使用两种包装法之一： 每板21片，然后停药一周；每板28片，其中21片避孕药，跟着一周[[安慰剂|安慰剂]]例如糖片或是[[鐵|鐵]]質補充劑。 <ref name="Birth Control Pills">Stacey, Dawn. [http://contraception.about.com/od/prescriptionoptions/p/ThePill.htm ''Birth Control Pills''] {{Wayback|url=http://contraception.about.com/od/prescriptionoptions/p/ThePill.htm |date=20090225125632 }} Accessed July 20, 2009</ref>

==效果==
复合口服避孕药作为目前最有效的避孕手段，有两种衡量有效率的方法。一种是完美服用比率，就是完全按要求服用；一种是第一年实际平均比率，就是考虑实际忘记服用等情况的比率。<ref name="hatcher">{{cite book|author=Trussell, James|year=2007|chapter=Contraceptive Efficacy|editor=Hatcher, Robert A., et al.|title=Contraceptive Technology|edition=19th rev.|pages=|location=New York|publisher=Ardent Media|isbn=0-9664902-0-7|chapterurl=http://www.contraceptivetechnology.com/table.html|access-date=2010-03-12|archive-date=2008-05-31|archive-url=https://web.archive.org/web/20080531095926/http://www.contraceptivetechnology.com/table.html|dead-url=no}}</ref> 

服用复合避孕药却意外怀孕的比例跟统计人群有关，典型的是第一年2-8%。完美服用比率则为0.3%<ref name="hatcher" />。相比起来避孕套的第一年平均失败率14%，完美使用时失败率为3%，甚至一些西方医学专家不建议使用。<ref name="skouby">Skouby, SO. The European Journal of Contraception and Reproductive Health Care (2004) "Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries." 9(2):57-68</ref>

[[北京大学第三医院|北京大学第三医院]]研究發現，人流率和避孕药的使用率相关，数据表明[[大陸|大陸]]20―29岁的妇女人流率是62％，而[[荷兰|荷兰]]的人流率为5.1％。与之相对应的是[[大陸|大陸]]2.3%和荷兰36%的避孕药使用率。在15―45岁的女性中，[[法国|法国]]、[[澳大利亚|澳大利亚]]、[[英国|英国]]、[[瑞典|瑞典]]的避孕药使用率在20%―30%之间，人流率都在千分之十几的水平；排名最后的[[日本|日本]]人流率高达84％，其避孕药使用率只有1%。中國避孕失败的已婚妇女有56%使用避孕套，24%使用宫内节育器；而避孕失败的未婚妇女主要使用避孕套（71％）。研究表明，避孕药的可靠性比避孕套高10―15倍，比节育器高1.5―4倍<ref name="people" />。而事實上影響[[中國墮胎率|中國墮胎率]]的最大因素為國家[[一孩政策|一孩政策]]。

==作用机制==

复合避孕药的首要作用是阻止释放[[促性腺激素|促性腺激素]]的办法阻止排卵. <!--
  --><ref name="hatcher"/><!--
  --><ref name="speroff"/><!--
  --><ref name="loose">{{cite book |author=Loose, Davis S.; Stancel, George M. |editor=Brunton, Laurence L.; Lazo, John S.; Parker, Keith L. (eds.) |year=2006 |chapter=Estrogens and Progestins |title=Goodman & Gilman's The Pharmacological Basis of Therapeutics |edition=11th |pages=1541–1571 |location=New York |publisher=McGraw-Hill |isbn=0-07-142280-3}}</ref><!--
  --><ref name="glasier">{{cite book |last=Glasier |first=Anna |editor=DeGroot, Leslie J.; Jameson, J. Larry (eds.) |title=Endocrinology |edition=5th |year=2006 |publisher=Elsevier Saunders |location=Philadelphia |isbn=0-7216-0376-9 |pages=2993–3003 |chapter=Contraception}}</ref><!--
  --><ref name="rivera">{{cite journal |author=Rivera R, Yacobson I, Grimes D |year=1999 |title=The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices |journal=Am J Obstet Gynecol |volume=181 |issue=5 Pt 1 |pages=1263–9 |pmid=10561657 | doi = 10.1016/S0002-9378(99)70120-1}}</ref>

所有含有孕激素的作用机制是用增加宫颈液的粘稠度来阻止精子穿越[[宫颈|宫颈]]到达[[子宫|子宫]]和[[输卵管|输卵管]]。 <!--
  --><ref name="rivera">{{cite journal |author=Rivera R, Yacobson I, Grimes D |year=1999 |title=The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices |journal=Am J Obstet Gynecol |volume=181 |issue=5 Pt 1 |pages=1263–9 |pmid=10561657 | doi = 10.1016/S0002-9378(99)70120-1}}</ref>

==副作用==
不同的来源报告了不同类型的[[副作用|副作用]]，最常见的是[[突破出血|突破出血]]，即在两个[[月经|月经]]周期之间出血。
[[新墨西哥州大学|新墨西哥州大学]]的研究表明大多数（60%）使用者报告完全没有副作用，绝大多数觉得有副作用的人报告只有非常轻微的副作用。1992法国的一篇法国报道说50%停止使用避孕药的妇女是因为[[月经不调|月经不调]]，例如突破出血或者月经停止。<!--
 --><ref name="serfaty">{{cite journal |author=Serfaty D |title=Medical aspects of oral contraceptive discontinuation |journal=Adv Contracept |volume=8 |issue=Suppl 1 |pages=21–33 |year=1992 |pmid=1442247 | doi = 10.1007/BF01849448}}<br>
{{cite journal |last=Sanders |first=Stephanie A. | coauthors = Cynthia A. Graham, Jennifer L. Bass and John Bancroft |title=A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation | journal = Contraception | volume = 64 | issue = 1 |pages=51–58 |url=http://www.contraceptionjournal.org/article/PIIS0010782401002189/abstract |accessdate=2007-03-02 | doi = 10.1016/S0010-7824(01)00218-9 |pmid=11535214 |date=July 2001}}</ref>

===长期作用===
英国The GPs Oral Contraception Study研究显示45岁之前停止服药5-9年之前的妇女有略微高比例的死亡率。但年纪大一些后这些服用过避孕药的妇女的死亡率显著下降。
此项目的研究者说，避孕药可以有效预防肠道、子宫和卵巢癌。但Hannaford教授推断原因也有可能服用避孕药的妇女更关心自己的健康，做更多的体检。他说“这个研究带来的信息是，如果妇女长期服用避孕药，他们的健康问题的风险并没有增加，甚至对健康更有益”，但是“我们并不推荐妇女用服用避孕药的办法防治相关癌症”<ref name="JoSteele" >{{cite news | author=Jo Steele |title=Take The Pill 'for  a long life' | publisher=London Metro|date=2010-03-12}}</ref>。

=== 血栓 ===
请见[[#注意事项和禁忌症|#注意事项和禁忌症]]一节

=== 乳腺癌风险有限 ===
关于[[乳腺癌|乳腺癌]]风险和荷尔蒙类避孕药的研究是复杂而看似矛盾的。<!--
  --><ref>{{cite web |author=FPA |title=The combined pill - Are there any risks? |url=http://www.fpa.org.uk/information/leaflets/documents_and_pdfs/detail.cfm?contentid=130#8 |publisher=[[Family_Planning_Association|Family Planning Association]] (UK) |accessdate=2007-01-08 |date=April 2005 |archive-date=2007-02-08 |archive-url=https://web.archive.org/web/20070208155326/http://www.fpa.org.uk/information/leaflets/documents_and_pdfs/detail.cfm?contentID=130#8 |dead-url=yes }}</ref>总体来说，大多数研究没有发现口服避孕药对于乳腺癌风险的总体提升<ref name=":0">{{Cite web|title=The Pill and Breast Cancer Risk|url=https://www.webmd.com/sex/birth-control/pill-breast-cancer-risk|accessdate=2019-07-23|work=WebMD|language=en|archive-date=2020-11-28|archive-url=https://web.archive.org/web/20201128145318/https://www.webmd.com/sex/birth-control/pill-breast-cancer-risk|dead-url=no}}</ref>。即使发现风险提升，此效果也在停药后几年内消失，且阳性研究涉及的多为雌激素含量较高的老版避孕药。不过BRAC突变携带者需谨慎服用避孕药。避孕药对乳腺癌风险的提升也受年龄影响，45岁以上最高。<ref name=":0" />

1996年的一个对总数超过15万妇女，54 个乳腺癌研究的综合数据分析发现：“分析结果提供的有力证据表明两个主要结论：第一，正在服用复方口服避孕药和已经停药10年以内的妇女增加了很小的''被诊断''出乳腺癌的风险。第二，对于停药10年以后的妇女的风险则没有明显增加。在已经被确诊乳腺癌的妇女中，服用复合口服避孕药的比从未用药的人更早的被诊断出来。”<!--
  --><ref name="oxford 1996a" />
数据分析表明，口服避孕药对乳腺癌有極少或者完全没有生理学影响，且服用避孕藥的妇女通常更注重自身健康並做了更多的妇科检查，因此更容易发现早期的乳腺癌而非末期轉移。<!--
  --><ref name="oxford 1996b">{{cite journal|title=Breast cancer and hormonal contraceptives: further results|author=Collaborative Group on Hormonal Factors in Breast Cancer|journal=Contraception|issue=3 Suppl|year=1996|volume=54|pages=1S–106S|pmid=8899264}}</ref><!--
  --><ref>{{cite journal|title=Oral contraception and the risk of breast cancer|author=Plu-Bureau G, Lê M|journal=Contracept Fertil Sex|issue=4|year=1997|volume=25|pages=301–5|pmid=9229520}} - pooled re-analysis of original data from 54 studies representing about 90% of the published epidemiological studies, prior to introduction of third generation pills.<!-- 3rd generation pills not yet been available for 20 yrs to complete similar analysis--></ref>

===对体重的影响===
避孕药对体重的影响主要是由1970年代避孕药多有一定雄激素活性造成的，而新型避孕药中的孕激素对雄激素受体没有亲和力，不会增重。<ref name="people" />

1992年法国一篇文章报道了一组15–19岁[[青少年|青少年]]在1982年停止用药的调查报告，20–25% 报告说因为体重增加还有25%因为害怕得[[癌症|癌症]]。<!--
 --><ref name="serfaty">{{cite journal |author=Serfaty D |title=Medical aspects of oral contraceptive discontinuation |journal=Adv Contracept |volume=8 |issue=Suppl 1 |pages=21–33 |year=1992 |pmid=1442247 | doi = 10.1007/BF01849448}}<br>
{{cite journal |last=Sanders |first=Stephanie A. | coauthors = Cynthia A. Graham, Jennifer L. Bass and John Bancroft |title=A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation | journal = Contraception | volume = 64 | issue = 1 |pages=51–58 |url=http://www.contraceptionjournal.org/article/PIIS0010782401002189/abstract |accessdate=2007-03-02 | doi = 10.1016/S0010-7824(01)00218-9 |pmid=11535214 |date=July 2001}}</ref>

今天，很多医生都认为大众认为避孕药造成体重增加的想法是不正确甚至危险的。一篇英国研究总结说没有任何证据表面现代低剂量避孕药会导致体重增加，但是因为担心体重增加却会导致停药而意外怀孕，对于少女来说这种现象尤其严重。<!--
 --><ref name=humreprod/>

===对性能力的影响===
复合避孕药对性能力可能有好的或者坏的影响。妇女因为不用担心[[怀孕|怀孕]]，在[[心理|心理]]上可以尽情享受性的快乐。复合避孕药可能使[[阴道|阴道]]更加润滑；但也有妇女报告说性慾低下而导致[[阴道|阴道]]干燥。<ref name="hn">{{cite book |author=Hatcher & Nelson |editor=Hatcher, Robert D. |chapter=Combined Hormonal Contraceptive Methods |title=Contraceptive technology |publisher=Ardent Media, Inc |location=New York |year=2004 |pages=403,432,434 |edition=18th |isbn=0-9664902-5-8 }}</ref><ref>{{cite book |author=Darney, Philip D.; Speroff, Leon |title=A clinical guide for contraception |publisher=Lippincott Williams & Wilkins |location=Hagerstown, MD |year=2005 |edition=4th |pages=72 |isbn=0-7817-6488-2 }}</ref>

===对生殖能力的影响===
对于已经淘汰的长效避孕药才有停药3―6个月再[[妊娠|妊娠]]的说法。但对于现代复合避孕药，没有任何临床研究证明需要停药。”研究发现，服用避孕药的妇女怀孕生产后，后代出现[[先天性心脏缺陷|先天性心脏缺陷]]和[[肢体短小|肢体短小]]的风险与没有服过避孕药的妇女的孩子相比，基本没有差别。郑淑蓉教授认为，避孕药能有效防止异位妊娠，阻止下生殖道感染發展为[[盆腔感染|盆腔感染]]，对保护女性生育能力有好处。<ref name="people" />

===对忧郁症的影响===
[[大脑|大脑]]中[[血清素|血清素]]的含量是影响[[忧郁症|忧郁症]]的重要因素。早期的避孕药含有大量激素，被证明会显著降低大脑[[血清素|血清素]]水平。<ref name="hatcher"/> 
而单一激素避孕药会导致忧郁症恶化。<!--
 --><ref name="aphrodite">{{cite paper |author=Katherine Burnett-Watson |title=Is The Pill Playing Havoc With Your Mental Health? |date=October 2005 |url=http://www.aphroditewomenshealth.com/news/hormones_depression.shtml |accessdate=2007-03-20 |deadurl=yes |archiveurl=https://web.archive.org/web/20070320002408/http://www.aphroditewomenshealth.com/news/hormones_depression.shtml |archivedate=2007-03-20 }}, which cites:<br>
:{{cite journal |author=Kulkarni J, Liew J, Garland K |title=Depression associated with combined oral contraceptives—a pilot study |journal=Aust Fam Physician |volume=34 |issue=11 |pages=990 |year=2005 |pmid=16299641}}</ref>
但低激素复合口服避孕药对忧郁症的影响仍然有争议。<ref name="hatcher"/>  <ref name="pmid5018716">{{cite journal |author=Rose DP, Adams PW |title=Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone |journal=J. Clin. Pathol. |volume=25 |issue=3 |pages=252–8 |pmid=5018716 |pmc=477273 |doi= 10.1136/jcp.25.3.252|url=https://archive.org/details/sim_journal-of-clinical-pathology_1972-03_25_3/page/252|date=March 1972}}</ref>

===高血压===
[[孕激素|孕激素]]会影响体内[[氨基肽酶|氨基肽酶]]的水平，这种[[酶|酶]]可能破坏[[血管舒缓激肽|血管舒缓激肽]]，最终有可能提高[[高血压|高血压]]的风险。<ref>{{Cite web |url=http://www.ncbi.nlm.nih.gov/pubmed/19126663?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2 |title=存档副本 |access-date=2010-03-12 |archive-date=2019-05-23 |archive-url=https://web.archive.org/web/20190523190114/https://www.ncbi.nlm.nih.gov/pubmed/19126663?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2 |dead-url=no }}</ref>

=== 脱发 ===
就像妇女生育后脱发一样，停止服用避孕药后女性体内激素的变化可能导致短时间的脱发，但过一段时间就会长回来。<ref>{{cite news  | title=Female hair loss treatment hope  | url=http://news.bbc.co.uk/2/hi/health/4824348.stm  | date=2006-03-21  | accessdate=2010-03-15  | archive-date=2021-02-14  | archive-url=https://web.archive.org/web/20210214050809/http://news.bbc.co.uk/2/hi/health/4824348.stm  | dead-url=no  }}</ref> 

==有益健康==
口服避孕药还可以预防[[直肠癌|直肠癌]]，治疗[[盆腔炎|盆腔炎]]、[[痛经|痛经]]、[[经前综合症|经前综合症]]和[[粉刺|粉刺]]。<ref name="pmid18710356">{{cite journal |author=Huber JC, Bentz EK, Ott J, Tempfer CB |title=Non-contraceptive benefits of oral contraceptives |journal=Expert Opin Pharmacother |volume=9 |issue=13 |pages=2317–25 |pmid=18710356 |doi=10.1517/14656566.9.13.2317 |url=http://www.informapharmascience.com/doi/abs/10.1517/14656566.9.13.2317 |date=September 2008 |deadurl=yes |archiveurl=https://archive.is/20130111072141/http://www.informapharmascience.com/doi/abs/10.1517/14656566.9.13.2317 |archivedate=2013-01-11 }}</ref> 并且避孕药减缓[[子宫内膜异位|子宫内膜异位]]和[[卵巢多囊综合症|卵巢多囊综合症]]和[[贫血|贫血]]的症状。<ref>An Introduction to Behavioral Endocrinology, Randy J Nelson, 3rd edition, Sinauer</ref>

据[[阿伯丁大学|阿伯丁大学]]Philip Hannaford教授领导的the Royal College of GPs Oral Contraception Study研究小组在英国医学期刊（British Medical Journal）上发表的最新研究成果：经过40年的研究，统计了超过46,000个妇女进行对比试验，发现每100,000服用避孕药的妇女中，比其他避孕方式的平均少死亡52人
<ref name="dm">{{cite news |author=Daniel Martin |url=http://www.dailymail.co.uk/health/article-1257336/Women-use-Pill-cut-chances-dying-cancer-heart-disease.html |title=Is the Pill saving lives? Women who use it 'cut their chances of dying of cancer and heart disease' |publisher=Daily Mail |date=2010-03-12 |accessdate=2010-03-12 |archive-date=2021-01-26 |archive-url=https://web.archive.org/web/20210126155220/https://www.dailymail.co.uk/health/article-1257336/Women-use-Pill-cut-chances-dying-cancer-heart-disease.html |dead-url=no }}</ref>，服用避孕药的妇女预期死亡率比不服用者低12%<ref name="JoSteele" />。这个研究基于旧式的避孕药，因此新式（激素含量更低）的避孕药可能没有这个“功效”。

研究表明使用口服避孕药至少5年以上，可以使以后一生得[[卵巢癌|卵巢癌]]的几率降低50%。<ref name="pmid17302189">{{cite journal |author=Bast RC, Brewer M, Zou C, ''et al.'' |title=Prevention and early detection of ovarian cancer: mission impossible? |journal=Recent Results Cancer Res. |volume=174 |issue= |pages=91–100 |year=2007 |pmid=17302189 |doi= 10.1007/978-3-540-37696-5_9|url=}}</ref>另一篇论文则表明，比起从未用过口服避孕药的妇女来说，使用复合避孕药可以使卵巢癌几率降低40%，子宫内膜癌降低50%，而且随用药时间增加获得癌症风险逐渐降低，用药超过10年则使这两种癌症几率降低80%。<!--
 --><ref name="speroff">{{cite book |author=Speroff, Leon; Darney, Philip D. |year=2005 |chapter=Oral Contraception |title=A Clinical Guide for Contraception |edition=4th |pages=21–138 |location=Philadelphia |publisher=Lippincott Williams & Wilkins |isbn=0-781-76488-2}}</ref>

== 注意事项和禁忌症 ==
口服避孕药可能会影响[[凝血|凝血]]，因为其中的雌激素影响了凝血因子的合成，增加[[深静脉血栓|深静脉血栓]]（DVT）和[[肺栓塞|肺栓塞]]，[[中风|中风]]和[[心肌梗死|心肌梗死]]的风险。一般被认为复方口服避孕药的禁忌症为：已经发病的[[心血管疾病|心血管疾病]]患者、家族内有女性血栓类病史（如遗传因子[[V_Leiden|V Leiden]]突变）、[[高胆固醇血症|高胆固醇血症]]（高胆固醇）、35岁以上的[[烟草|吸烟者]]，以及生育后21天内的妇女（或哺乳期的28天内的，或有血栓风险的，在生育后的42天内不得服用。风险因素包括肥胖或进行过剖腹产）。<ref>{{Cite web|title=激素避孕方法|url=https://www.msdmanuals.com/zh/%E9%A6%96%E9%A1%B5/%E5%A5%B3%E6%80%A7%E5%81%A5%E5%BA%B7%E9%97%AE%E9%A2%98/%E8%AE%A1%E5%88%92%E7%94%9F%E8%82%B2/%E6%BF%80%E7%B4%A0%E9%81%BF%E5%AD%95%E6%96%B9%E6%B3%95|accessdate=2019-07-23|work=默克诊疗手册家庭版|language=zh|archive-date=2019-03-29|archive-url=https://web.archive.org/web/20190329150542/https://www.msdmanuals.com/zh/%E9%A6%96%E9%A1%B5/%E5%A5%B3%E6%80%A7%E5%81%A5%E5%BA%B7%E9%97%AE%E9%A2%98/%E8%AE%A1%E5%88%92%E7%94%9F%E8%82%B2/%E6%BF%80%E7%B4%A0%E9%81%BF%E5%AD%95%E6%96%B9%E6%B3%95|dead-url=no}}</ref><ref>{{Cite web|title=AOGS：选择避孕药应考虑血栓风险|url=http://yao.dxy.cn/article/37081|accessdate=2019-07-23|work=yao.dxy.cn|archive-date=2019-07-23|archive-url=https://web.archive.org/web/20190723094008/http://yao.dxy.cn/article/37081|dead-url=no}}</ref><ref>{{Cite journal|title=Hormonal contraception and venous thromboembolism|url=https://www.ncbi.nlm.nih.gov/pubmed/22568831|last=Lidegaard|first=Øjvind|last2=Milsom|first2=Ian|date=2012-7|journal=Acta Obstetricia Et Gynecologica Scandinavica|issue=7|doi=10.1111/j.1600-0412.2012.01444.x|volume=91|pages=769–778|issn=1600-0412|pmid=22568831|last3=Geirsson|first3=Reynir Tomas|last4=Skjeldestad|first4=Finn Egil|access-date=2019-07-23|archive-date=2019-07-23|archive-url=https://web.archive.org/web/20190723094001/https://www.ncbi.nlm.nih.gov/pubmed/22568831|dead-url=no}}</ref>单纯[[肥胖|肥胖]]不被认为是使用避孕药的禁忌症。<ref name="WHO recommend">{{cite book |title=Selected practice recommendations for contraceptive use|publisher=| author = World Health Organization. Reproductive Health and Research |isbn=9789241565400 |edition=Third |location=Geneva |pages=150 |oclc=985676200 |date=2017-01-12}}</ref>

医学权威现在已经普遍接受服用口服避孕药对健康造成的风险低于怀孕和生育<ref>{{cite book | author=Crooks, Robert L. and Karla Baur | title=Our Sexuality | url=https://archive.org/details/oursexuality0000croo_z0e9 | year=2005 | publisher=Thomson Wadsworth |location=Belmont, CA | isbn=0-534-65176-3}}</ref>。并且“任何避孕方法对健康的好处远远大于其风险”([[世界卫生组织|世界卫生组织]])<ref>[[WHO|WHO]] (2005). ''[http://www.who.int/reproductive-health/family_planning/counselling.htm Decision-Making Tool for Family Planning Clients and Providers] {{Wayback|url=http://www.who.int/reproductive-health/family_planning/counselling.htm |date=20070107004503 }} Appendix 10: Myths about contraception''</ref> 一些组织则认为，比较一种避孕方法，把一个避孕方法与怀孕相比是不恰当的，而应该比较现有的避孕方法的安全性。<!--
 --><ref>{{cite web |last=Holck |first=Susan |title=Contraceptive Safety |work=Special Challenges in Third World Women's Health |publisher=1989 Annual Meeting of the American Public Health Association |url=http://www.users.interport.net/i/w/iwhc/sc_cs.html |accessdate=2006-10-07 |archive-date=2017-11-08 |archive-url=https://web.archive.org/web/20171108202427/http://www.users.interport.net/i/w/iwhc/sc_cs.html |dead-url=no }}</ref>

== 非治疗用途 ==

避孕药的荷尔蒙可以用来治疗一些临床疾病，如[[多囊卵巢综合征|多囊卵巢综合征]] （PCOS）的，[[子宫内膜异位症|子宫内膜异位症]]，[[子宫腺肌病|子宫腺肌病]]，与月经贫血，[[痛经|痛经]]。此外，口服避孕药是治疗轻度或中度痤疮的常规药物。 避孕药也可以调整不规则和异常的月经周期，和[[功能失调性子宫出血|功能失调性子宫出血]]。此外，避孕药提供了一些对非癌症的乳房发育保护，防止宫外孕和阴道干燥，和更年期有关的性交疼痛。<ref>{{cite journal |author=Huber J, Walch K |title=Treating acne with oral contraceptives: use of lower doses. |url=https://archive.org/details/sim_contraception_2006-01_73_1/page/23 | journal = Contraception | volume = 73 | issue = 1 |pages=23–9 |year=2006|pmid = 16371290 | doi = 10.1016/j.contraception.2005.07.010}}</ref>

==参考资料== 
{{reflist|colwidth=30em}}

{{Birth control methods}}
{{Authority control}}
[[Category:激素避孕|Category:激素避孕]]
[[Category:性革命|Category:性革命]]
[[Category:肝毒素|Category:肝毒素]]

[[fr:Contraception_orale|fr:Contraception orale]]
[[ru:Гормональная_контрацепция|ru:Гормональная контрацепция]]